Report offers ways to address cybersecurity challenges posed by legacy medical devicesÂ
The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, . The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts.
Related News Articles
Headline
The Cybersecurity and Infrastructure Security Agency April 17 released guidance to reduce risks associated with a reported breach of Oracle cloud services.…
Headline
The National Counterintelligence and Security Center, the FBI, and the Defense Counterintelligence and Security Center yesterday released guidance on…
AHA Cyber Intel
While the rate of cyberattacks on hospitals has risen dramatically, the severity of the impacts has also grown exponentially. Let’s look at the state of cyber…
Headline
The House Energy and Commerce Oversight and Investigations Subcommittee April 1 discussed cybersecurity threats in legacy medical devices during a hearing. The…
Headline
Despite elegant efforts to design for safe use, rigorous standards and regulatory requirements, and lots of training of health care professionals, there’s…
Headline
The Trump Administration March 28 announced that it renewed for one year the public emergency for ongoing malicious cyber-enabled activities against the U.S.…